Artiva Biotherapeutics, Inc. ARTV Common stock, capital shares reserved for future issuance
Common stock, capital shares reserved for future issuance at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s common stock, capital shares reserved for future issuance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s common stock, capital shares reserved for future issuance?
- Artiva Biotherapeutics, Inc. (ARTV) reported common stock, capital shares reserved for future issuance of $9.03M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s common stock, capital shares reserved for future issuance changed year-over-year?
- Artiva Biotherapeutics, Inc.'s common stock, capital shares reserved for future issuance increased by 44.5% year-over-year, from $6.25M to $9.03M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s common stock, capital shares reserved for future issuance?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s common stock, capital shares reserved for future issuance has grown at a -5.1% compound annual growth rate (CAGR), from $7.91M to $7.13M.